Amring Pharmaceuticals is a privately-held generic pharmaceutical company active in global markets geared to supplying unique and specialized products. The company is part of the global Amring Pharmaceuticals business and is partnered with well-established global biopharmaceutical companies. Amring is uniquely positioned to leverage its partners’ expertise in peptide-based drugs and biotechnology derived medicines, as well as patient-friendly drug delivery systems, sterile manufacturing and other state-of-the-art technologies.

Amring is committed to putting people first in all it does, providing customers with high quality products at a reasonable cost

NEWS
March 1, 2017

Amring Pharmaceuticals Inc. acquired six ANDA’s from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture between Luitpold Pharmaceuticals, Inc. and Alphagen Laboratories Inc.  The acquired ANDAs include niche otic and ophthalmic pharmaceuticals that will bring value to our customers and patients.   Click here to learn more.

April 29, 2016

Amring Pharmaceuticals Inc. and Integrated Commercialization Solutions Inc.
(ICS) have agreed to expand the current list of provided services to include Account Receivables and
Cash Applications. This consolidates the order to cash process to one central location making
Amring’s customer service experience more efficient.

April 7, 2016

Amring Pharmaceuticals Inc. begins shipping Desmopressin Acetate Solution 0.01% Nasal Spray, authorized generic to Ferring Pharmaceuticals’ DDAVP®

March 14, 2016

Amring Pharmaceuticals Inc. begins shipping Tranexamic Acid Tablets 650mg Tablets, authorized generic to Ferring Pharmaceuticals’ Lysteda®

January 25, 2016

Amring Pharmaceuticals Inc. begins shipping Desmopressin Acetate Solution 10mcg/1mL Injection available in 10mL multi‐dose vials and 1mL ampules, authorized generic to Ferring Pharmaceuticals’ DDAVP®

December 14, 2015

Amring Pharmaceuticals Inc. and Integrated Commercialization Solutions
Inc. (ICS) entered into a long- term third party logistics agreement. With this agreement, ICS becomes Amring’s 3PL provider, which includes customer, warehousing, and distribution services.

December 14, 2015

Amring Pharmaceuticals Inc. goes commercial and ships their first units of Desmopressin Acetate Tablets, authorized generic to Ferring Pharmaceuticals’ DDAVP®

June 8, 2015

Amring Pharmaceuticals Inc. opens the doors on its new US headquarters and home office in Berwyn, PA.